IOVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Iovance Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 4.395 USD 11.83%

Market Cap: $2B

	Iovance Biotherapeutics Inc NASDAQ:IOVA	US
B	Bank Mandiri (Persero) Tbk PT XMUN:PQ9	ID
E	Empresa Nacional de Telecomunicaciones SA SGO:ENTEL	CL
	Springer Nature AG & Co KgaA XETRA:SPG	DE

Profitability Summary

Iovance Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

37%

Negative 3Y Average Gross Margin

-256%

Gross Margin is Increasing

-754% > 37%

Negative Operating Margin

-127%

Negative 3Y Average Operating Margin

-25 626%

Operating Margin is Increasing

-178 496% > -127%

Negative Net Margin

-124%

Negative 3Y Average Net Margin

-24 935%

Net Margin is Increasing

-174 517% > -124%

Negative Free Cash Flow Margin

-107%

Negative 3Y Average Free Cash Flow Margin

-21 417%

Free Cash Flow Margin is Increasing

-147 783% > -107%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-96%

ROIC is Increasing

-133% > -63%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.